Becker's ASC Review

Nov_Dec_2018_ASC

Issue link: https://beckershealthcare.uberflip.com/i/1058309

Contents of this Issue

Navigation

Page 44 of 55

45 SUPPLY CHAIN 10 strategies to streamline ASC supply chain management By Rachel Popa I nventory Optimization Solutions shared 10 ways ASCs can improve supply chain management. Here are the key takeaways: 1. Order preparation. Barcode scanners can capture information on products needing to be ordered. 2. Order approval. Overspending can be avoided by shiing the approval to the front of the purchasing process by reducing orders for products. 3. Order submission. Ordering can be streamlined through technology such as au- tofax or email. Automating order submission also frees up time for supply chain personnel. 4. Vendor communication. Using data interchange technology, supply chain staff can communicate with suppliers to receive confirmation that orders have been placed, and when the supplies are on their way. 5. Mobile apps. Supply chain apps al- low staff to place orders electronically, and approvers can approve and submit them seamlessly. 6. Tracking costs. Technology can help ASC administrators keep track of business plans, track inventory and manage costs. 7. Standardize products. Working with group purchasing organizations to determine which products can be standardized can help ASCs save costs. 8. Take advantage of the cloud. Using cloud technology will save staff time because the soware can be adapted to fit an organi- zation's structure, and soware doesn't need to be installed. 9. Electronic three match invoice ap- proval. Checking invoices to ensure they match the confirmed price and quantity can improve supply chain accuracy. 10. Automate orders. Automating orders can free up time for ASC staff members who have to wear multiple hats. n 5 major developments in the US medical device industry By Angie Stewart T he medical device industry's global annual sales are projected to grow more than 5 percent annually and reach almost $800 billion by 2030, NASDAQ reported. With more than $180 billion in revenues, the U.S. medical device market is the largest in the world. Here are five key developments in the U.S. medical device market: 1. Medtech tax is abolished. The 2.3 percent excise tax on medtech manufacturers was suspended for two years. It will go back into effect beginning Jan. 1, 2020. The repeal has spurred investments in the sector and is expected to boost hiring and investment at 9,000 U.S. medical device manufacturers. 2. Mergers and acquisitions surge. There has been ongoing merger and acquisition activity in the industry. The MedTech arena saw a 50 percent spike in M&A activity in 2017, putting the aggregate M&A value at more than $200 billion. Major recent acquisitions include BD's acquisition of C. R. Bard and Johnson & Johnson's buyout of Actelion. 3. Pharmacy benefit managers and health insurers consolidate. Health insurers have been collaborating with PBMs in the medtech space to stream- line drug supply chain costs. Through strategic M&A policies, dominant medical device players have expanded customer bases, gained leverage and improved cash flow while alleviating pricing pressure and competition. 4. Medtech undergoes digital revolution. Robotic surgery, big-data analyt- ics, bio printing, 3-D printing, EHRs, predictive analytics, real-time alerting and revenue cycle management services are trending in the medtech industry. According to some reports, AI adopters have reduced healthcare costs by 50 percent and improved patient outcomes by at least the same amount. Mean- while, the industry has seen a rise in minimally invasive surgeries, increased demand for liquid biopsy tests and IT leveraged to improve patient care. 5. Trade war fears take hold. President Donald Trump has targeted 10 sec- tors for higher tariffs. The trade dispute will likely have a significant impact on healthcare and medical equipment, as U.S. medtech firms currently export $4.7 billion to China each year and medical device imports from China amount to $5 billion. U.S. medical device exports totaled $52 billion last year. n Drugs & medical supplies costs at ASCs across the US — 7 statistics By Angie Stewart D rugs and medical supplies comprise almost 25 per- cent of net revenue at ASCs nationwide, according to VMG Health's 2018 Multi-Specialty ASC Benchmarking Study. Here are seven statistics on the median cost of drugs and medical supplies per case: 1. All facilities: $140 2. Atlantic: $132 3. Midwest: $163 4. Mountain: $133 5. Northeast: $130 6. Pacific: $172 7. South: $141 n

Articles in this issue

Links on this page

view archives of Becker's ASC Review - Nov_Dec_2018_ASC